The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 23, 2024

Filed:

Feb. 28, 2020
Applicant:

Amorepacific Corporation, Seoul, KR;

Inventors:

Gyeyoung Choi, Yongin-si, KR;

Hyunjin Nam, Yongin-si, KR;

Miyoung Park, Yongin-si, KR;

Kyoungmi Jung, Yongin-si, KR;

Jihae Lee, Yongin-si, KR;

Chang Soon Choi, Yongin-si, KR;

Youngho Park, Yongin-si, KR;

Jong Hwa Roh, Yongin-si, KR;

Eunsil Park, Yongin-si, KR;

Jaehong Park, Yongin-si, KR;

Kwanghyun Shin, Yongin-si, KR;

Byoung Young Woo, Yongin-si, KR;

Kiwha Lee, Yongin-si, KR;

Wonkyung Cho, Yongin-si, KR;

Joonho Choi, Yongin-si, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 17/04 (2006.01); A61K 31/44 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/44 (2013.01); A61K 9/0014 (2013.01); A61P 17/04 (2018.01);
Abstract

Disclosed is a method for preventing or treating atopic dermatitis using TRPV1 receptor antagonist. More specifically, it may be possible to prevent and/or treat the atopic dermatitis without any side effects such as an increase in body temperature, epidermal atrophy, and the like by percutaneously administrating a composition for external use on the skin containing the TRPV1 receptor antagonist.


Find Patent Forward Citations

Loading…